Researcher.Life Logo

Cardio-Oncology : Impact Factor & More

eISSN: 2057-3804pISSN: 2057-3804
JournalOpen Access

Key Metrics

CiteScore
2.3
SNIP
0.88
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cardio-Oncology

Cardio-Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2090 | USD 2490 | GBP 1690
Publication Time7
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2015
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 7
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Cardio-Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cardio-Oncology

Risk of incident cardiovascular disease events among older Asian, Native Hawaiian, and Pacific Islander colorectal cancer survivors in the United States: a cohort study.
  • 12 Jan 2026
  • Cardio-oncology (London, England)
The ROOT-CTRCD study: exploring the relationship of oral health to cancer therapy-related cardiac dysfunction in HER2-positive breast cancer patients.
  • 10 Jan 2026
  • Cardio-oncology (London, England)
Prevalence of obstructive coronary artery disease in asymptomatic cancer patients with elevated troponin levels.
  • 10 Jan 2026
  • Cardio-oncology (London, England)
Dexrazoxane Cardioprotection in pediatric ALL: a historical control cohort study.
  • 9 Jan 2026
  • Cardio-oncology (London, England)
Cardioprotective medications and the incidence of cardiovascular events in patients treated with radiotherapy: a systematic review and meta-analysis.
  • 8 Jan 2026
  • Cardio-oncology (London, England)
Can flaxseed "milk" prevent anthracycline mediated cardiotoxicity in women with breast cancer (CANFLAX-BC)?
  • 8 Jan 2026
  • Cardio-oncology (London, England)
Risk of incident cardiovascular disease events among older Asian, Native Hawaiian, and Pacific Islander colorectal cancer survivors in the United States: a cohort study.
  • 12 Jan 2026
  • Cardio-oncology (London, England)
The ROOT-CTRCD study: exploring the relationship of oral health to cancer therapy-related cardiac dysfunction in HER2-positive breast cancer patients.
  • 10 Jan 2026
  • Cardio-oncology (London, England)
Prevalence of obstructive coronary artery disease in asymptomatic cancer patients with elevated troponin levels.
  • 10 Jan 2026
  • Cardio-oncology (London, England)
Dexrazoxane Cardioprotection in pediatric ALL: a historical control cohort study.
  • 9 Jan 2026
  • Cardio-oncology (London, England)
Cardioprotective medications and the incidence of cardiovascular events in patients treated with radiotherapy: a systematic review and meta-analysis.
  • 8 Jan 2026
  • Cardio-oncology (London, England)
Can flaxseed "milk" prevent anthracycline mediated cardiotoxicity in women with breast cancer (CANFLAX-BC)?
  • 8 Jan 2026
  • Cardio-oncology (London, England)

FAQs on Cardio-Oncology